Steve DeNelsky

Director at VisionCare

Mr. DeNelsky has served as a member of our board of directors since 2015. Mr. DeNelsky has over 20 years of healthcare investment experience across all sectors including medical devices and diagnostics. Prior to founding LSAF in 2013, Mr. DeNelsky worked for 12 years at various hedge funds as a healthcare analyst and portfolio manager. Mr.DeNelsky managed Sapphire Capital, a healthcare only hedge fund that returned mid-high teens returns from 2005-2007 and attracted over $230 million in capital. Mr. DeNelsky served as lead director of Amicas (NASDAQ: AMCS), a healthcare technology company, from 2001-2010. Prior to his direct investment experience, Mr. DeNelsky was a Senior Equity Analyst at CS First Boston, Deutsche Bank and Furman Selz covering a variety of healthcare services companies. Before coming to Wall Street, Mr. DeNelsky worked in the healthcare industry for a healthcare consulting, mergers and acquisitions and valuation firm based in Washington D.C.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


VisionCare

VisionCare has developed the first FDA-approved telescope prosthesis demonstrated to improve vision and quality of life in individuals with End-Stage AMD. The telescope implant technology is based on wide-angle micro-optics that, in combination with th...


Industries

Employees

11-50

Links